PHARMA-CHAP-89

Page 1:

Main Ideas:

  • Anti-infective agents are drugs designed to target foreign organisms that have invaded and infected the body.

    • They have selective toxicity, meaning they affect proteins or enzyme systems used only by the infecting organism but not by human cells.

  • There are two types of anti-infective agents: bactericidal and bacteriostatic.

    • Bactericidal drugs cause death of the cells they affect.

    • Bacteriostatic drugs interfere with the cells' ability to reproduce or divide, preventing or slowing cell replication.

  • The goal of anti-infective therapy is to reduce the population of invading organisms to a point where the human immune response can eliminate them.

  • Immunocompromised individuals may have difficulty effectively dealing with invading organisms due to factors such as malnutrition, age, or AIDS.

  • Resistance refers to the ability of microorganisms to adapt over time and become unaffected by a particular anti-infective drug.

Page 2:

Main Ideas:

  • Gentamicin is an aminoglycoside antibiotic that inhibits protein synthesis in susceptible strains of gram-negative bacteria.

    • It can cause severe renal damage and ototoxicity.

  • Meropenem is an IV antibiotic from the carbapenem class that inhibits the synthesis of cell walls in susceptible bacteria.

    • It is used to treat polymicrobial and drug-resistant infections.

    • It can cause uncomfortable gastrointestinal effects.

  • Vancomycin interferes with cell wall synthesis in susceptible bacteria.

    • It is used to treat patients who are intolerant or allergic to penicillin.

    • IV vancomycin may be highly toxic and is reserved for serious and severe infections.

  • Anti-infective agents can be used for prophylaxis to prevent infections before they occur or to prevent a second infection.

  • The treatment of systemic infections involves identifying the pathogen, determining its sensitivity, and using combination therapy.

  • Sensitivity testing evaluates pathogens obtained in a culture to determine which anti-infectives will be effective against the organisms causing the infection.

  • Anti-infective therapy can have adverse reactions, including kidney damage, gastrointestinal toxicity, neurotoxicity, hypersensitive reactions, and superinfections.

Page 3:

Main Ideas:

  • Antibiotics are chemicals that inhibit specific bacteria.

  • Bacteria can be categorized based on their types of cell wall using Gram staining.

  • Gram-positive bacteria have more peptidoglycan layers in their cell walls and are associated with respiratory tract and soft tissue infections.

  • Gram-negative bacteria have a thin layer of peptidoglycan and are associated with genitourinary or gastrointestinal tract infections.

  • Aerobic bacteria depend on oxygen for survival, while anaerobic bacteria do not use oxygen.

  • Synergistic antibiotics have a combined effect that is greater or can treat more severe infections.

  • Aminoglycosides are a group of antibiotics used to treat infections caused by aerobic gram-negative bacilli.

  • Aminoglycosides are bactericidal and inhibit protein synthesis in susceptible strains of aerobic gram-negative bacteria.

  • They are poorly absorbed from the GI tract, rapidly absorbed after IM injection, and widely distributed throughout the body.

  • Contraindications and cautions for aminoglycosides include known allergy, renal disease, preexisting hearing loss, and conditions like myasthenia gravis or parkinsonism.

Page 4

Adverse Effects of Aminoglycosides

  • Central Nervous System:

    • Ototoxicity, irreversible deafness

    • Vestibular paralysis

    • Confusion, depression, disorientation

    • Numbness, tingling, weakness

  • GI effects:

    • Nausea, vomiting, diarrhea

    • Weight loss

    • Stomatitis

  • Cardiac effects:

    • Palpitations

    • Hypotension

    • Hypertension

Clinically Important Drug-Drug Interactions

  • Synergistic bactericidal effect with penicillins or cephalosporins

  • Increased incidence of ototoxicity when combined with loop diuretics

  • Increased risk of nephrotoxicity when combined with vancomycin

  • Increased neuromuscular blockade with paralysis when given with anesthetics, nondepolarizing neuromuscular blockers, succinylcholine, or citrate anticoagulated blood

Carbapenems

  • Broad-spectrum beta-lactam antibiotics effective against gram-positive and gram-negative bacteria

  • Bactericidal action by inhibiting cell membrane synthesis in susceptible bacteria

  • Used to treat serious infections

Page 5

Pharmacokinetics of Carbapenems

  • Rapid absorption if given IM, peak levels at the end of IV infusion

  • Widely distributed throughout the body

  • Varies in ability to cross placenta or enter human milk

  • Excreted unchanged in urine, average half-life of 1 to 4 hours IV infusion

Contraindications and Cautions for Carbapenems

  • Caution in case of allergy to carbapenems or beta-lactams

  • Caution during pregnancy and lactation due to potential adverse effects to fetus

Adverse Effects of Carbapenems

  • Toxic effects on the GI tract:

    • Pseudomembranous colitis

    • Clostridium Difficile diarrhea

    • Nausea, vomiting leading to dehydration and electrolyte imbalances

  • Superinfections can occur

  • CNS effects:

    • Headache, dizziness, altered mental state

    • Seizures reported

Clinically Important Drug-Drug Interactions for Carbapenems

  • Decreased serum valproic acid levels and increased risk of seizures when combined with valproic acid

  • Increased risk of seizures when combined with ganciclovir

Page 6

Cephalosporins

  • Beta-lactam antibiotics similar to penicillins in structure and activity

  • Bactericidal or bacteriostatic depending on dose and specific drug

Pharmacokinetics of Cephalosporins

  • Primarily excreted unchanged in urine

  • Lower doses may be prescribed for patients with renal impairment

Contraindications and Cautions for Cephalosporins

  • Allergies to cephalosporins or penicillins, cross-sensitivity may occur

  • Caution with hepatic or renal impairment due to kidney toxicity

Clinically Important Drug-Drug Interactions for Cephalosporins

  • Increased risk of nephrotoxicity when taken with aminoglycosides

  • Increased bleeding when taken with warfarin

Adverse Effects of Cephalosporins

  • Common adverse effects involve the GI tract:

    • Nausea, vomiting, diarrhea, anorexia, abdominal pain, flatulence

  • Pseudomembranous colitis is a potentially dangerous disorder

  • CNS symptoms:

    • Headache, dizziness, lethargy, paresthesia

  • Nephrotoxicity associated with use in patients with renal insufficiency

Fluoroquinolones

  • Synthetic bactericidal antibiotics with broad-spectrum activity

Therapeutic Actions and Indications of Fluoroquinolones

  • Enter bacterial cell and interfere with DNA enzymes necessary for growth and reproduction of bacteria

  • Used to treat infections caused by susceptible strains of gram-positive and gram-negative bacteria

Pharmacokinetics of Fluoroquinolones

  • Absorbed from GI tract, metabolized in liver, excreted in urine and feces

Contraindications and Cautions for Fluoroquinolones

  • Multiple boxed warnings for potential serious adverse effects:

    • Tendinitis, tendon rupture, peripheral neuropathy, CNS effects, exacerbation of muscle weakness in patients with myasthenia gravis

Adverse Effects of Fluoroquinolones

  • Serious effects:

    • Tendinitis, tendon rupture, peripheral neuropathy, CNS effects, diarrhea, liver toxicity

  • Common effects:

    • Headache, dizziness, insomnia, depression

    • Nausea, vomiting, diarrhea, dry mouth

    • Bone marrow depression

Clinically Important Drug-Drug Interactions for Fluoroquinolones

  • Decreased therapeutic effect when taken with iron salts, sucralfate, multivitamins, calcium or magnesium supplements, or antacids

  • Increased levels of theophylline when combined with theophylline

  • Increased risk of CNS stimulation when combined with nonsteroidal anti-inflammatory drugs

  • Increased risk of tendonitis and tendon rupture when combined with corticosteroids

Penicillins and Penicillinase Resistance

  • First antibiotic for clinical use, modified to act on resistant bacteria

Therapeutic Actions and Indications of Penicillins

  • Bactericidal effects by interfering with cell wall synthesis in susceptible bacteria

Pharmacokinetics of Penicillins

  • Rapid absorption from GI tract, sensitive to gastric acid levels

  • Should be taken on an empty stomach for adequate absorption

Contraindications and Cautions for Penicillins

  • Contraindicated in patients with allergies to penicillin or other allergens

  • Caution in patients with renal disease, lower doses necessary

  • Limited use in pregnancy and lactation due to potential adverse effects on the infant

Adverse Effects of Penicillins

  • Major adverse effects involve the GI tract:

    • Nausea, vomiting, diarrhea, abdominal pain, glossitis, stomatitis, gastritis, sore mouth, furry tongue

Clinically Important Drug-Drug Interactions for Penicillins

  • Inactivation of aminoglycosides when combined with parenteral penicillins

Sulfonamides

  • Inhibit folic acid synthesis

Therapeutic Actions and Indications of Sulfonamides

  • Folic acid is necessary for the synthesis of purines and pyrimidines, precursors of RNA and DNA

  • Used for cells to grow and reproduce

Pharmacokinetics of Sulfonamides

  • Teratogenic, distributed into human milk

  • Given orally, absorbed from GI tract

Contraindications and Cautions for Sulfonamides

  • Not routinely used during pregnancy due to potential birth defects

  • Caution in older adults due to increased incidence of thrombocytopenia, hyperkalemia, and folate deficiency

Adverse Effects of Sulfonamides

  • GI tract effects:

    • Nausea, vomiting, diarrhea, abdominal pain, anorexia, stomatitis

  • Hepatic injury

Note: This summary includes all the main ideas and supporting details from the given transcript.

Page 7

Adverse Effects of Tetracyclines

  • Irritation of the GI tract and death of normal bacteria

    • Renal effects: crystalluria, hematuria, hyperkalemia, proteinuria

    • CNS effects: headache, dizziness, vertigo, ataxia, convulsions, depression

    • Bone marrow depression

    • Dermatological effects: photosensitivity, Stevens-Johnson syndrome

Clinically Important Drug-Drug Interactions

  • Increased risk of hypoglycemia when taken with antidiabetic agents glyburide or glipizide

  • Increased risk of hyperkalemia when combined with medications like ace inhibitors and potassium sparing diuretics

  • Risk of nephrotoxicity when taken with cyclosporine

Therapeutic Actions and Indications of Tetracyclines

  • Bacteriostatic, inhibiting protein synthesis in a wide range of bacteria

Pharmacokinetics of Tetracyclines

  • Absorbed adequately but not completely from the GI tract

  • Absorption affected by food, iron, calcium, and other drugs in the stomach

Contraindications and Cautions of Tetracyclines

  • Caution in children younger than 8 years of age due to potential damage to developing bones and teeth

Adverse Effects of Tetracyclines

  • Direct irritation of the GI tract and hepatotoxicity

  • Damage to teeth and bones

  • Dermatological effects: photosensitivity, rash, superinfection

  • Local effects: pain and stinging with topical application

  • Hematological effects: hemolytic anemia, bone marrow depression

  • Hypersensitivity reactions: urticaria to anaphylaxis, intracranial hypertension

Clinically Important Drug-Drug Interactions of Tetracyclines

  • Digoxin toxicity increases when taken concurrently

  • Decreased absorption when combined with calcium salts, magnesium salts, zinc salts, aluminum salts, bismuth salts, and iron

Clinically Important Drug-Food Interactions of Tetracyclines

  • Oral tetracyclines are not effective if taken with food or dairy products

  • Should be administered on an empty stomach with water 1 hour before or 2 to 3 hours after any meal or other medication

Page 8

Antituberculosis Drugs

  • Tuberculosis can cause serious damage in the lungs, GU tract, bones, and meninges

Leprostatic Drugs

  • Dapsone is used to treat leprosy and pneumocystis jirovecii pneumonia in AIDS patients

  • Also used for various infections caused by susceptible bacteria and for brown recluse spider bites

  • Topical form can be used to treat acne

Thalidomide (Thalomide)

  • Immunomodulatory drug used to treat cutaneous reactions due to leprosy

  • Dosage: 100-300 mg/d PO, up to 400 can be administered

Erythema Nodosum Leprosum

  • Complication of leprosy that causes inflammatory skin nodules and systemic symptoms like fever, malaise, and neuritis

Therapeutic Actions and Indications of Antimycobacterials

  • Acts on the DNA and RNA of bacteria, leading to lack of growth and bacterial death

Rifadin, Rimactane

  • Bactericidal drugs mostly active against mycobacteria

  • Resistance to rifampin develops quickly if used as monotherapy

Adverse Effects of Antimycobacterials

  • CNS effects: neuritis, dizziness, headache, malaise, drowsiness, hallucinations

Clinically Important Drug-Drug Interactions of Antimycobacterials

  • Concurrent use of isoniazid, rifampin, and pyrazinamide increases the risk of hepatotoxicity

  • Eating foods with tyramine and taking isoniazid can cause histamine reaction

  • Taking isoniazid with alcohol can increase liver damage

Lincosamides

  • Similar to macrolides, bacteriostatic drugs that interfere with protein synthesis of gram-positive bacteria

  • Examples: clindamycin (Cleocin), lincomycin (Lincocin)

Therapeutic Actions and Indications of Lincosamides

  • React at the same site in bacterial protein synthesis and are effective against the same strains of bacteria

  • Used to treat infections caused by gram-positive and some anaerobic bacteria

Pharmacokinetics of Lincosamides

  • Absorbed rapidly from GI tract or from IM injections, typically administered IV

  • Metabolized in the liver and excreted in the urine and feces

  • Cross the placenta and enter human milk

Page 9

Contraindications and Cautions

  • Caution with hepatic impairment

    • Interference with metabolism and excretion of the drug

  • Dose adjustment recommended for renal impairment

Adverse Effects

  • Severe GI reactions, including fatal pseudomembranous colitis

  • Drug of choice for serious infections caused by susceptible bacteria

Lipoglycopeptides

  • Class of antibiotics introduced in 2010

  • Includes Telavancin, Dalbavancin, Oritavancin, and Vancomycin

Therapeutic Actions and Indications

  • Inhibit bacterial cell wall synthesis

  • Bind to bacterial membrane and disrupt membrane barrier function

  • Treat complicated skin and skin structure infections in adults

Pharmacokinetics

  • Available as IV drugs, only Vancomycin has an oral form

  • Oral Vancomycin poorly absorbed and not used for systemic infections

  • Lipoglycopeptides reach peak levels at the end of infusion

Adverse Effects

  • Toxic effects on GI tract: nausea, vomiting, taste alterations, diarrhea, loss of appetite

  • Risk of C. difficile diarrhea

  • Nephrotoxicity

Clinically Important Drug-Drug Interaction

  • Increased risk of prolonged QT interval and arrhythmias with Telavancin and other drugs known to prolong QT interval

  • Increased risk of nephrotoxicity with Telavancin and Vancomycin when combined with other nephrotoxic drugs

Macrolides

  • Antibiotics that bind to the ribosome and interfere with protein synthesis in susceptible bacteria

  • Includes Erythromycin, Azithromycin, Clarithromycin, and Fidaxomicin

Therapeutic Actions and Indications

  • Bactericidal at high doses or bacteriostatic

  • Bind to ribosomes and change protein synthesis, preventing cell division or causing cell death

  • Treat various bacterial infections

Pharmacokinetics

  • Widely distributed throughout the body

  • Cross the placenta and enter human milk

  • Erythromycin and Azithromycin primarily metabolized in the liver, excreted in bile to feces

  • Half-life of Erythromycin is 1.6 hours

Page 10

Clarithromycin

  • Partially excreted unchanged in the urine

  • Half-life of Azithromycin is 68 hours, useful for patients with trouble remembering

  • Half-life of Clarithromycin is 3 to 7 hours

Fidaxomicin

  • Minimally absorbed systemically, acts in the GI tract

  • Metabolized in the GI tract and excreted in the feces

  • Half-life of 9 hours

Contraindications and Cautions

  • Contraindicated in patients with allergy that can cause cross-sensitivity

  • Caution with hepatic dysfunction

  • Caution with lactating mothers, except for Fidaxomicin which is not absorbed systemically

  • Caution with pregnant women, potential adverse effects on fetus or infant

Adverse Effects

  • GI tract effects: abdominal cramping, anorexia, diarrhea, vomiting, pseudomembranous colitis

  • Neurological symptoms: confusion, abnormal thinking, uncontrollable emotions

  • Hypersensitivity reactions ranging from rash to anaphylaxis and superinfection

Clinically Important Drug-Drug Interactions

  • Increased serum levels of digoxin when taken with macrolides

  • Increased metabolic changes in the liver when taken with oral anticoagulants, carbamazepine

Clinically Important Drug-Food Interactions

  • Food in the stomach decreases absorption of oral macrolides, except for Azithromycin

  • Antibiotics should be taken on an empty stomach with a full 8-oz glass of water 1 hour before or 2 to 3 hours after meals

Oxazolidinones

  • Class: Tedizolid and Linezolid

Therapeutic Actions and Indications

  • Interfere with protein synthesis on the bacterial ribosome

  • Act as MAO inhibitors

  • Effective against vancomycin-resistant strains of MRSA and penicillin-resistant pneumococci

  • Tedizolid FDA approved for skin and skin structure infections, diabetic foot infections without osteomyelitis

Pharmacokinetics

  • Tedizolid available for oral or IV use, half-life of 12 hours, metabolized in liver and excreted in urine and feces

  • Linezolid available for oral or IV use, half-life of 5 hours, metabolized in liver and excreted in urine

Page 11

Contraindications and Cautions

  • Allergy to drug

  • Caution with phenylketonuria (oral suspension of Linezolid)

  • Caution with patients taking MAO inhibitors

  • Caution with pregnant and lactating patients

  • Caution with hepatic impairment, pheochromocytoma, hypertension, hyperthyroidism, and bone marrow suppression

Adverse Effects

  • CNS effects: headache, insomnia, dizziness

  • GI tract effects: dry mouth, nausea, vomiting, diarrhea, potential for pseudomembranous colitis

  • Optic neuritis, thrombocytopenia, bone marrow suppression, hypertension

Drug-Drug Interactions

  • Risk of hypertension when combined with drugs that increase blood pressure

  • Risk of bleeding and thrombocytopenia when combined with NSAIDs and platelet inhibitors

  • Potential for serious serotonin syndrome if used with serotonergic drugs

Drug-Food Interactions

  • Potential for serious to life-threatening hypertension when combined with large amounts of tyramine-containing foods

Monobactam Antibiotic

  • Aztreonam

Therapeutic Actions and Indications

  • Effective against gram-negative enterobacteria

  • No effect on gram-positive or anaerobic bacteria

  • Disrupts bacterial cell wall synthesis

  • Indicated for the treatment of urinary tract, skin, intra-abdominal, and gynecological infections

Pharmacokinetics

  • Available for IV and IM use only

  • Reaches peak effects levels immediately if administered IV, slower if administered IM

  • Half-life of 1.5 to 2 hours

Contraindications and Cautions

  • Caution with history of acute allergic reaction to penicillins or cephalosporins

  • Caution with renal dysfunction

  • Caution with pregnant and lactating mothers

Adverse Effects

  • Local GI tract effects: nausea, GI upset, vomiting, diarrhea

  • Hepatic enzyme elevations

  • Inflammation, phlebitis, and discomfort at injection sites

  • Anaphylaxis

Page 12: Clinically Important Drug-Drug Interactions

  • Aztreonam and aminoglycosides may have a synergistic effect when used together to treat certain organisms.

End of Transcript

  • This note is transcribed from a pharmacology midterm coverage lecture.

  • The instructor is Joel F. Defensor, RN, MAN, USRN.

  • The transcription was done by Braille Justine T. Boncales, SN.

  • The lecture refers to Sir Joel's PowerPoint presentation and discussion.